Stay updated on Efficacy of SubQ DMB-3115 vs Stelara in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of SubQ DMB-3115 vs Stelara in Psoriasis Clinical Trial page.

Latest updates to the Efficacy of SubQ DMB-3115 vs Stelara in Psoriasis Clinical Trial page
- Check6 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference2%
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference2%
- Check28 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check35 days agoNo Change Detected
- Check42 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference3%
- Check70 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check78 days agoChange DetectedThe page has undergone significant content changes regarding the study of DMB-3115 for treating moderate to severe chronic plaque psoriasis, including updates to the version number.SummaryDifference7%
Stay in the know with updates to Efficacy of SubQ DMB-3115 vs Stelara in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of SubQ DMB-3115 vs Stelara in Psoriasis Clinical Trial page.